New-onset acute heart failure and ventricular tachycardia after therapy with a tumor necrosis factor antagonist.
Boyer
J F
JF
Jamard
B
B
El Mahou
S
S
Laroche
M
M
Mazières
B
B
Cantagrel
A
A
Constantin
A
A
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017180:Tachycardia, Ventricular / Q000150:complications / Q000209:etiology* / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab